StonvexLoading…
StonvexStonvexStonvexCore line items from ENSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.07M | $5.21M | $2.23M | $2.52M |
Operating Income | $-10.24M | $-6.73M | $-10.72M | $-24.22M |
Net Income | $-10.18M | $-7.99M | $-10.63M | $-24.21M |
EPS (Diluted) | $-3.98 | $-11.45 | $-70.40 | $-139.42 |
Total Assets | $7.45M | $5.60M | $2.71M | $5.89M |
Total Liabilities | $4.57M | $2.22M | $3.36M | $9.91M |
Cash & Equivalents | $4.31M | $3.50M | $1.12M | $3.15M |
Free Cash Flow OCF − CapEx | $-7.93M | Not available | Not available | Not available |
Shares Outstanding | 4.57M | 1.36M | 209.74K | 534.49K |